Call to tighten psych screening for mefloquine

Australia should follow the lead of Europe and introduce mandatory neuropsychiatric risk screening as a condition of prescribing the antimalarial mefloquine, according to a travel medicine expert.

Doctors in EU countries are now required to fill out a contraindication checklist before writing a mefloquine script for malaria prophylaxis, to rule out patients with a history of mental illness and other risk factors that could trigger adverse effects when taking the drug.

Dr Deborah Mills, medical director of Dr Deb’s Travel Medicine Clinics in

Latest

Trending